Clinical and epidemiological aspects of human parvovirus B19 infection in an urban area in Brazil (Niterói City Area, State of Rio de Janeiro, Brazil)

Memorias do Instituto Oswaldo Cruz

Volumn 97, Issue 7, 2002, Pages 965-970

  De Oliveira, Solange Artimos ^a   Camacho, Luiz Antonio Bastos ^b   Pereira, Antonio Carlos De Medeiros ^a   Faillace, Tereza Filomena ^c   Setúbal, Sérgio ^a   Do Nascimento, Jussara Pereira ^d,e  

^a HOSPITAL UNIVERSITÁRIO ANTÔNIO PEDRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Policlinica Comunitaria S Rosa   (Brazil)

^d FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^e Instituto de Technologia em Imunobiologicos   (Brazil)

Author keywords

Brazil; Clinical features; Diagnosis; Epidemiology; Human parvovirus B19; IgM; Niter i, Rio de Janeiro

Indexed keywords

IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BRAZIL; CHILD; ENZYME IMMUNOASSAY; ERYTHEMA INFECTIOSUM; FEMALE; HUMAN; IMMUNOLOGY; INFANT; MALE; MIDDLE AGED; NEWBORN; PARVOVIRUS; PATHOLOGY; PRESCHOOL CHILD; URBAN POPULATION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; BRAZIL; CHILD; CHILD, PRESCHOOL; ERYTHEMA INFECTIOSUM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN M; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PARVOVIRUS B19, HUMAN; URBAN POPULATION;

EID: 0036781165     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0074-02762002000700007     Document Type: Article

References (33)

1. Ager FA, Chin TDY, Poland JD 1996. Epidemic erythema infectiosum. N Engl J Med 275: 1326-1331.
2. Anderson MJ, Jones SE, Fisher-Hoch SO, Lewis E, Hall SM, Bartlett CR, Cohen BJ, Mortimer PP, Pereira MS 1983. Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet 1: 1378.
3. Brown KE 1997. Human parvovirus B19 epidemiology and clinical manifestations. In LJ Anderson, NS Young (eds), Human Parvovirus B19, Monographs in Virology, Basel Karget, vol. 20, p. 42-60.
4. Brown T, Anand A. Ritchie LD, Clewley JP, Reid TMS 1984. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet ii: 1033-1034.
5. Cohen BJ 1995 Parvovirus B19: an expanding spectrum of disease. BMJ 311. 1549-1552.
6. Cossart YEA, Field AM, Cabt B, Widdows D 1975. Parvovirus-like particles in human sera. Lancet i: 72-73.
7. Cubel RCN, Alferes ACR, Cohen BJ, Nascimcnto JP 1994. Application to immunoglobulin M capture hemadherence assays of hemagglutination of monkey erythrocytes by native and recombinant human parvovirus B19 antigens. J Clin Microbiol 32: 1997-1999.
8. Cubel RCN, Siqueira MM, Santos EO, Pires MF, Cruz CMF, Nascimento JP 1997. Human parvovirus B19 infections among exanthematic diseases notified as measles. Rev Soc Bras Med Trop 30: 15-20.
9. Cubel RCN, Valadào MC, Pereira WV, Magalhàes MC, Nascimento JP 1992. Aplastic crisis due to human parvovirus B19 infection in hereditary hemolytic anaemia. Rev Inst Med Trop Sào Paulo 34: 479-482.
10. Dean AG, Dean JA, Coulombier D, Brendel KA, Smith DC, Burton AH, Dicker RC, Sullivan K, Fagan RF, Arner TG 1994. Epi Info Version 6, Centers for Diseases Control and Prevention, Atlanta, GA.
11. Freitas RB, Gusmão SRB, Durigon EL, Linhares AC 1999. Survey of parvovirus B19 infection in a cohort of pregnant women in Belém, Brazil. Braz J Infect Dis 3. 6-14.
12. Freitas RB, Linhares AC, Miranda MFR, Gabbay IV 1988. Novo agente de doença exantemática na Amazônia: o parvovirus "B19". Bol Epidemiol (Brazil. Ministério da Saúde, Fundação Sesp) 20: 1-4.
13. Freitas RB, Miranda MFR, Shirley J, Tudor R, Desselberger U, Linhares AC 1993. Parvovirus B19 antibodies in sera of patients with unexplained exanthemata from Belém, Pará, Brazil. Mem Inst Oswaldo Cruz 88: 497-499.
14. Freitas RB, Wong D, Boswell F, Miranda MF, Linhares AC, Shirley J, Desselberger 1990. Prevalence of human parvovirus B19 and rubellavirus infections in urban and remote rural areas in Northern Brazil. J Med Virol 32: 203-208.
15. Hummel KB, Erdman DD, Heath J, Bellini WJ 1992. Baculo-virus expression of the nucreoprotein gene of measles virus and utility of the recombinant protein in diagnosis enzyme immunoassays. J Clin Microbiol 30: 2874-2880.
16. Kuno G, Gomez I, Gubler DJ 1987. Detecting artificial anti-dengue IgM immune complexes using an enzyme linked immunosorbent assay. Am J Trop Med Hyg 36: 153-159.
17. Kurtzman GJ, Cohen BJ, Field AM, Oseas R, Blaese RM, Young NS 1989 Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 84: 1114-1123.
18. Lauer BA, Maccormack JN, Wilfcrt C 1976. Erythema infectiosum: an elementary school outbreak. Am J Dis Child 130: 252-254.
19. Mielle A, Nogueira MB, Lisboa C, Yamashita CA. Costa SD, Lotufo JPB, Vieira SE, Durigon E, Stewvien K, Ejzenberg B, Baldacci RR, Okay Y 1995. Infecçào por parvovirus: apresentaçào atipica em três crianças. Pediatria (São Paulo) 17: 197-201.
20. Ministérioda Saúde. Brasil 1999. Fundação Nacional de Saúde. Plano de Erradicação do Sarampo e Controle da Rubéola e Sindrome da Rubéola Congênita, Brasilia.
21. Miranda MFR, Linhares AC, Shirley JA 1989. Fifth disease in children living in Belém, Brazil. Rev Inst Med Trop São Paulo 31: 359-362.
22. Nascimento JP, Buckley MM, Brown KH, Cohen BJ 1990. The prevalence of antibody to human parvovirus B19 in Rio de Janeiro, Brazil. Rev Inst Med Trop São Paulo 32: 41-45.
23. Nascimento JP, Mistchenko A, Cohen BJ 1998. Laboratory diagnosis of acute human parvovirus infection by specific IgM detection. Rev Inst Med Trop São Paulo 40: 265-266.
24. Nogueira RMR, Miagostovich MP, Cavalcanti SMB, Marzo-chi KBF, Schatzmayr HG 1992. Levels of IgM antibodies against dengue virus in Rio de Janeiro, Brazil. Res Virol 143: 423-427
25. Oliveira SA, Brandão AB, Fernandas DG, Bettini LR, Carvalho AB, Pereira ACM, Azevedo KM, Nascimento JP 1996. Human parvovirus B19 infection: clinical and epidemiological study of 24 cases. Rev Inst Med Trop São Paulo 38: 323-327.
26. Oliveira SA, Pereira ACM. Rocha ALC, Pereira SB, Faillace TF, Nascimento JP 2001a. Papel da parvovirose humana na vigilância epidemiológica da rubéola e outras viroses exantemáticas. Rev Soc Bras Med Trop 34 (Supl. 1): 440-441.
27. Oliveira SA, Siqueira MM, Camacho LAB, Nogueira RM, Spinetti CCJ, Cubel-Garcia RCN, Knowles W, Brown DWG 2001b. The aetiology of maculopapular rash diseases in Niterói, State of Rio de Janeiro, Brazil: implications for measles surveillance. Epidemiol Infect 127: 509-516.
28. Pattison JR, Jones SE, Hodgson J, Davis LR, White JM, Stroud CE, Murtaza L 1981. Parvovirus infections and hypoplastic crisis in sickle-cell anaemia. Lancer i: 664-665.
29. Reid DM, Reid TMS, Brown T, Rennie JAN, Eastmond CJ 1985. Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet i: 422-425.
30. Rodis JF 1999. Parvovirus infection. Clin Obstet Gynecol 42: 107-120.
31. Serjeant GR, Serjeant BE, Thomas PE, Anderson MJ, Patou G, Pattison JR 1993. Human parvovirus infection in homozygous sickle cell disease. Lancet 341: 1237-1240.
32. Ward KN, Gray JJ, Efstathiou S 1989. Brief report: primary human herpesvirus-6 infection in a patient following liver transplantation from a seropositive donor J Med Virol 28: 69-72.
33. Woolf AD, Campion GV, Chishick A, Wise S, Cohen BJ, Klouda PT, Caul O, Dieppe PA 1989. Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med 149: 1153-1156.